|
| |
HematologicDownload PDF containing detailed information.
Recent Publications on Hematologic: |  |
VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience.
CHOP (cyclophosphamide, adriamycin, vincristine, and prednisolone) plus... | 21st November, 2009
| Department of Hematology, Kishiwada City Hospital, 1001 Gakuhara-cho,
| Arch Gerontol Geriatr. 2009 Nov 17.
DOI Direct Link |
Nonmyeloablative HLA-Haploidentical BMT with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome.
Although some reports have found increasing HLA disparity between donor... | 21st November, 2009
| Johns Hopkins University, Baltimore, MD.
| Biol Blood Marrow Transplant. 2009 Nov 16.
DOI Direct Link |
Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
Purpose. To review current knowledge about tumor lysis syndrome (TLS), a... | 20th November, 2009
| Wake Forest University Baptist Medical Center.
| J Oncol Pharm Pract. 2009 Nov 18.
DOI Direct Link |
Indications and Diagnostic Utility of Bone Marrow Examination in Different Bone Marrow Disorders in Iran.
The shortage of published literature regarding the indications for bone... | 20th November, 2009
| Department of Pathology, Rasoul Akram Hospital, School of Medicine, Iran
| Lab Hematol. 2009 Dec 1;15(4):38-44.
DOI Direct Link |
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
OBJECTIVE: GOG 172 showed a survival benefit with intraperitoneal (IP)... | 20th November, 2009
| Division of Gynecologic Oncology, Department of Obstetrics and Gynecology,
| Gynecol Oncol. 2009 Nov 16.
DOI Direct Link |
→View more research publications. |
Press Releases About Hematologic:
|
 |
| The American Society of Hematology Elects New Leadership |
3rd November, 2009 |
American Society of Hematology |
WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology, the world's largest professional society of blood specialists, welcomes five new officers to its Executive
|
| Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD |
30th October, 2009 |
Shire plc |
HONOLULU, Oct. 30 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb
|
| New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohn's Patients |
26th October, 2009 |
UCB |
-- Bacterial, viral and other infections due to opportunistic pathogens.
The risks and benefits of treatment with CIMZIA should be carefully considered prior to initiating therapy in patients
|
| New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure |
26th October, 2009 |
UCB |
-- Efficacy of certolizumab pegol is not affected by baseline
anti-infliximab antibody status in patients with Crohn's disease with
secondary infliximab failure (Abstract
|
| UCB's Cimzia(R) (certolizumab pegol), Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid Arthritis |
17th October, 2009 |
UCB |
-- Bacterial, viral and other infections due to opportunistic pathogens.
The risks and benefits of treatment with Cimzia® should be carefully considered prior to initiating therapy in
|
Companies working in the area of Hematologic from Bioportfolio's Biocorporate database : | |
| Company Name | |
NeXstar Pharmaceuticals, Inc., is an integrated biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life...
www.nexstar.com/ View full profile
| |
Salmedix, Inc. is a San Diego-based biopharmaceutical company formed to in-license, develop and commercialize new cancer drugs, with an initial focus on hematologic cancers. Salmedix is developing...
www.salmedix.com/ View full profile
| |
Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with...
www.kepivance.com View full profile
| | →View more Hematologic related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for Hematologic scientists - we have details of around 4617 individuals working on Hematologic .
This page has been viewed 312 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Hematologic across BioPortfolio, or for Hematologic Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
